炎症性肠病中的整合素抑制剂：从治疗性抗体到小分子药物 - Suppr | 超能文献

Integrin Inhibitors in Inflammatory Bowel Disease: From Therapeutic Antibodies to Small-Molecule Drugs.

作者信息

Panés Julian

机构信息

Inflammatory Bowel Disease Unit, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.

出版信息

Gastroenterology. 2021 Dec;161(6):1791-1793. doi: 10.1053/j.gastro.2021.09.016. Epub 2021 Sep 14.

DOI:10.1053/j.gastro.2021.09.016

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Integrin Inhibitors in Inflammatory Bowel Disease: From Therapeutic Antibodies to Small-Molecule Drugs.炎症性肠病中的整合素抑制剂：从治疗性抗体到小分子药物

Gastroenterology. 2021 Dec;161(6):1791-1793. doi: 10.1053/j.gastro.2021.09.016. Epub 2021 Sep 14.

2

The role of integrin antagonists in the treatment of inflammatory bowel disease.整合素拮抗剂在炎症性肠病治疗中的作用。

Expert Opin Biol Ther. 2014 Dec;14(12):1815-23. doi: 10.1517/14712598.2014.967209. Epub 2014 Oct 7.

3

Lymphocyte homing antagonists in the treatment of inflammatory bowel diseases.淋巴细胞归巢拮抗剂在炎症性肠病治疗中的应用

Gastroenterol Clin North Am. 2014 Sep;43(3):581-601. doi: 10.1016/j.gtc.2014.05.012. Epub 2014 Jun 25.

4

Anti-inflammatory peptides and proteins in inflammatory bowel disease.炎症性肠病中的抗炎肽和蛋白质

Curr Opin Investig Drugs. 2001 Oct;2(10):1387-94.

5

Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease.系统评价与荟萃分析：炎症性肠病患者接受抗整合素抗体治疗期间的机会性感染和恶性肿瘤

Aliment Pharmacol Ther. 2015 Jun;41(12):1227-36. doi: 10.1111/apt.13215. Epub 2015 Apr 22.

6

Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.用于治疗炎症性肠病的新型药物疗法的生理基础。I. 炎症性肠病中抗粘附分子疗法的免疫学及治疗潜力。

Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G169-74. doi: 10.1152/ajpgi.00423.2004.

7

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies.整合素在炎症性肠病发病机制中的作用：已批准和正在研究的抗整合素疗法。

Med Res Rev. 2020 Jan;40(1):245-262. doi: 10.1002/med.21601. Epub 2019 Jun 19.

8

The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.维多珠单抗（一种正在研发用于治疗炎症性肠病的抗α4β7整合素治疗性抗体）的结合特异性和选择性拮抗作用。

J Pharmacol Exp Ther. 2009 Sep;330(3):864-75. doi: 10.1124/jpet.109.153973. Epub 2009 Jun 9.

9

Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go.炎症性肠病中的抗黏附分子疗法：成败难料。

Autoimmun Rev. 2008 May;7(5):364-9. doi: 10.1016/j.autrev.2008.01.002. Epub 2008 Feb 12.

10

Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.炎症性肠病中的黏附分子：对肠道炎症的治疗意义

Dig Liver Dis. 2005 Nov;37(11):811-8. doi: 10.1016/j.dld.2005.03.013. Epub 2005 Sep 13.

引用本文的文献

1

Effects of β2 Integrins on Osteoclasts, Macrophages, Chondrocytes, and Synovial Fibroblasts in Osteoarthritis.β2 整合素对骨关节炎中破骨细胞、巨噬细胞、软骨细胞和滑膜成纤维细胞的影响。

Biomolecules. 2022 Nov 8;12(11):1653. doi: 10.3390/biom12111653.